Divi's Laboratories Schedules Board Meeting for Q2FY27 Results on 7th Nov'26
Divis Laboratories Ltd 路 Intimation 路 07 Nov 2026, 5:30 am
Divi's Laboratories Schedules Board Meeting for Q2FY27 Results on 7th Nov'26 Divi's Laboratories Limited announced that its Board of Directors will meet on 7th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. In accordance with insider trading regulations, the trading window for dealing in company securities has been closed since 1st Oct'26 and will remain shut until 9th Nov'26, concluding 48 hours post-results declaration.
Original exchange filing (PDF)
More announcements from Divis Laboratories Ltd
- submission of transcript of Q2Fy27 earnings call held on November 07, 2026. 路 13 Nov 2026
- Intimation of audio link of Q2FY26 earnings call held on 07.11.2026. 路 07 Nov 2026
- As per enclosed. 路 07 Nov 2026
- As enclosed. 路 07 Nov 2026
- Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 07 Nov 2026
- Intimation of schedule of Q2FY2027 earnings call to be held on November 07, 2026 at 14:00 Hrs (IST). 路 07 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 07 Nov 2026
- Divi's Laboratories Limited has informed the Exchange about Board Meeting to be held on 07-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 07 Nov 2026
